{"id":55596,"date":"2023-04-06T16:06:24","date_gmt":"2023-04-06T14:06:24","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/subjectwell-expands-executive-leadership-to-realize-growth-strategy\/"},"modified":"2023-04-06T16:06:24","modified_gmt":"2023-04-06T14:06:24","slug":"subjectwell-expands-executive-leadership-to-realize-growth-strategy","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/subjectwell-expands-executive-leadership-to-realize-growth-strategy\/","title":{"rendered":"SubjectWell Expands Executive Leadership to Realize Growth Strategy"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<i>Former Medrio Executive Fred Martin Selected as CEO; SubjectWell Co-Founder Ivor Clarke Steps into COO Role<\/i><\/p>\n<p>AUSTIN, Texas&#8211;(BUSINESS WIRE)&#8211;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.subjectwell.com&amp;esheet=53376580&amp;newsitemid=20230406005235&amp;lan=en-US&amp;anchor=SubjectWell&amp;index=1&amp;md5=b4e747e64f1ab79c6d6ebbe417366a82\" rel=\"nofollow noopener\" shape=\"rect\">SubjectWell<\/a>, the largest engagement platform for matching patients with chronic health conditions to new care options, announced that clinical industry veteran Fred Martin has joined SubjectWell as CEO. After an extensive year-long search for a proven leader with the right combination of experience accelerating technical solutions and building investor relations, Fred\u2019s addition to SubjectWell\u2019s senior leadership team allows co-founder and previous CEO Ivor Clarke to move into the role of COO.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230406005235\/en\/1757902\/5\/fred_martin_headshot.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230406005235\/en\/1757902\/21\/fred_martin_headshot.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20230406005235\/en\/1757901\/5\/sw_logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230406005235\/en\/1757901\/21\/sw_logo.jpg\"><\/a><\/p>\n<p>\n\u201cI am honored to join this incredible company,\u201d said Fred Martin, new CEO. \u201cI am very motivated by SubjectWell\u2019s unique healthcare audience engagement platform, deep pharmaceutical relationships, and keen focus on data insights. The entire team sees an unprecedented opportunity to deliver value for patients, pharmaceutical clients, and shareholders.\u201d<\/p>\n<p>\nFred brings more than 25 years of experience in the healthcare industry to the executive team at SubjectWell. Most recently, he served as COO for Medrio, where multiple products launched under his purview led to five years of double-digit growth. Prior to that, Fred was VP of Product Management at Sigmacare, where he led the company to a successful exit. Earlier in his career at PointClickCare and Premier Inc. Healthcare, he built high-performing product teams and designed go-to-market strategies to capitalize on unrealized opportunities in the long-term care, hospital, and health system spaces. Fred holds a Communications BA from the University of Colorado Boulder, a Human Resources MILR from Cornell University, and a Marketing MBA from University of Michigan, Stephen M. Ross School of Business.<\/p>\n<p>\n\u201cFred will be instrumental in executing SubjectWell\u2019s vision for the growth of our core business of clinical trial patient recruitment and expansion via new product lines, while sharing our essential values of transparency and collaboration,\u201d said Ivor Clarke, new COO. \u201cFred\u2019s addition brings a depth of industry experience to our senior leadership team, and I\u2019m thrilled to have him leading SubjectWell into its next chapter of growth.\u201d<\/p>\n<p>\nThis announcement comes as SubjectWell focuses on expanding its risk-free clinical trial marketplace for patient recruitment and launching a unique offering that allows pharmaceutical companies to raise awareness and engagement of their post-approval treatments with verified patients.<\/p>\n<p>\n\u201cI see success and great opportunity in SubjectWell,\u201d added Fred Martin. \u201cBy coupling our proven audience engagement platform with my success driving best-in-class healthcare technologies, we are well positioned to deliver even greater value to our clients and investors.\u201d<\/p>\n<p>\n<b><i><span class=\"bwuline\">About SubjectWell<\/span><\/i><\/b><\/p>\n<p>\nSubjectWell, the audience engagement platform for healthcare, is raising awareness of clinical research in the general population \u2013 providing patients more choice and easy access to innovative treatment options. Visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.subjectwell.com&amp;esheet=53376580&amp;newsitemid=20230406005235&amp;lan=en-US&amp;anchor=SubjectWell.com&amp;index=2&amp;md5=6cab9c0911e9e6e04e1427c5056424f6\" rel=\"nofollow noopener\" shape=\"rect\">SubjectWell.com<\/a> to find out more.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Media<br \/>\n<br \/><\/b>Jillian Hammell<br \/>\n<br \/>Crowley Webb for SubjectWell<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#116;&#111;&#58;&#106;ill&#x69;&#x61;&#x6e;&#x2e;&#x68;&#97;&#109;&#109;ell&#x40;&#x63;&#x72;&#x6f;&#x77;&#108;&#101;&#121;web&#x62;&#x2e;&#x63;&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x6a;i&#x6c;&#108;&#x69;&#97;n&#x2e;&#104;&#x61;&#109;m&#x65;&#108;&#x6c;&#64;c&#x72;o&#x77;&#108;&#x65;&#x79;w&#x65;&#98;&#x62;&#46;c&#x6f;&#109;<\/a>, 716.844.7237<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Former Medrio Executive Fred Martin Selected as CEO; SubjectWell Co-Founder Ivor Clarke Steps into COO Role AUSTIN, Texas&#8211;(BUSINESS WIRE)&#8211;SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options, announced that clinical industry veteran Fred Martin has joined SubjectWell as CEO. After an extensive year-long search for a proven leader &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/subjectwell-expands-executive-leadership-to-realize-growth-strategy\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55596","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SubjectWell Expands Executive Leadership to Realize Growth Strategy - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/subjectwell-expands-executive-leadership-to-realize-growth-strategy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SubjectWell Expands Executive Leadership to Realize Growth Strategy - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Former Medrio Executive Fred Martin Selected as CEO; SubjectWell Co-Founder Ivor Clarke Steps into COO Role AUSTIN, Texas&#8211;(BUSINESS WIRE)&#8211;SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options, announced that clinical industry veteran Fred Martin has joined SubjectWell as CEO. After an extensive year-long search for a proven leader ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/subjectwell-expands-executive-leadership-to-realize-growth-strategy\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-06T14:06:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230406005235\/en\/1757902\/21\/fred_martin_headshot.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/subjectwell-expands-executive-leadership-to-realize-growth-strategy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/subjectwell-expands-executive-leadership-to-realize-growth-strategy\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"SubjectWell Expands Executive Leadership to Realize Growth Strategy\",\"datePublished\":\"2023-04-06T14:06:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/subjectwell-expands-executive-leadership-to-realize-growth-strategy\\\/\"},\"wordCount\":470,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/subjectwell-expands-executive-leadership-to-realize-growth-strategy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230406005235\\\/en\\\/1757902\\\/21\\\/fred_martin_headshot.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/subjectwell-expands-executive-leadership-to-realize-growth-strategy\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/subjectwell-expands-executive-leadership-to-realize-growth-strategy\\\/\",\"name\":\"SubjectWell Expands Executive Leadership to Realize Growth Strategy - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/subjectwell-expands-executive-leadership-to-realize-growth-strategy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/subjectwell-expands-executive-leadership-to-realize-growth-strategy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230406005235\\\/en\\\/1757902\\\/21\\\/fred_martin_headshot.jpg\",\"datePublished\":\"2023-04-06T14:06:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/subjectwell-expands-executive-leadership-to-realize-growth-strategy\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/subjectwell-expands-executive-leadership-to-realize-growth-strategy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/subjectwell-expands-executive-leadership-to-realize-growth-strategy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230406005235\\\/en\\\/1757902\\\/21\\\/fred_martin_headshot.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230406005235\\\/en\\\/1757902\\\/21\\\/fred_martin_headshot.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/subjectwell-expands-executive-leadership-to-realize-growth-strategy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SubjectWell Expands Executive Leadership to Realize Growth Strategy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SubjectWell Expands Executive Leadership to Realize Growth Strategy - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/subjectwell-expands-executive-leadership-to-realize-growth-strategy\/","og_locale":"en_US","og_type":"article","og_title":"SubjectWell Expands Executive Leadership to Realize Growth Strategy - Pharma Trend","og_description":"Former Medrio Executive Fred Martin Selected as CEO; SubjectWell Co-Founder Ivor Clarke Steps into COO Role AUSTIN, Texas&#8211;(BUSINESS WIRE)&#8211;SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options, announced that clinical industry veteran Fred Martin has joined SubjectWell as CEO. After an extensive year-long search for a proven leader ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/subjectwell-expands-executive-leadership-to-realize-growth-strategy\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-06T14:06:24+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230406005235\/en\/1757902\/21\/fred_martin_headshot.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/subjectwell-expands-executive-leadership-to-realize-growth-strategy\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/subjectwell-expands-executive-leadership-to-realize-growth-strategy\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"SubjectWell Expands Executive Leadership to Realize Growth Strategy","datePublished":"2023-04-06T14:06:24+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/subjectwell-expands-executive-leadership-to-realize-growth-strategy\/"},"wordCount":470,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/subjectwell-expands-executive-leadership-to-realize-growth-strategy\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230406005235\/en\/1757902\/21\/fred_martin_headshot.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/subjectwell-expands-executive-leadership-to-realize-growth-strategy\/","url":"https:\/\/pharma-trend.com\/en\/subjectwell-expands-executive-leadership-to-realize-growth-strategy\/","name":"SubjectWell Expands Executive Leadership to Realize Growth Strategy - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/subjectwell-expands-executive-leadership-to-realize-growth-strategy\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/subjectwell-expands-executive-leadership-to-realize-growth-strategy\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230406005235\/en\/1757902\/21\/fred_martin_headshot.jpg","datePublished":"2023-04-06T14:06:24+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/subjectwell-expands-executive-leadership-to-realize-growth-strategy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/subjectwell-expands-executive-leadership-to-realize-growth-strategy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/subjectwell-expands-executive-leadership-to-realize-growth-strategy\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230406005235\/en\/1757902\/21\/fred_martin_headshot.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230406005235\/en\/1757902\/21\/fred_martin_headshot.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/subjectwell-expands-executive-leadership-to-realize-growth-strategy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"SubjectWell Expands Executive Leadership to Realize Growth Strategy"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55596","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55596"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55596\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55596"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55596"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55596"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}